pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search
the cabinet

Drugs

8,127 products tracked · 1,831 matching

★ save view↓export CSV
phase
allMarketedPhase 3Phase 2Phase 1Preclinical
sort
catalystsrecentname
therapeutic area
allOncology1831Infectious Disease718Cardiology425Pulmonology396Immunology371Ophthalmology368Dermatology300Women's Health131
viewlistcards
  • Phase 2
    DCC-3009
    Gastrointestinal Stromal Tumor (GIST) Deciphera Pharmaceuticals Inc
  • Phase 1
    DF-6002
    Cervical Cancer Dragonfly Therapeutics Inc
  • Phase 1
    DFP-11207
    Gastric Cancer Delta-Fly Pharma Inc
  • Preclinical
← prev
page 17 of 62
next →
Pain89
Neurology1
DHA-dFdC
Leukemia
AIkido Labs Inc
  • Phase 1
    DIACC-3010
    Human Epidermal Growth Factor Receptor 2 Negative Breast… Evexta Bio SA
  • Phase 1
    DM-002
    Solid Tumor Doma Biopharmaceutical (Suzhou) Co Ltd
  • Phase 1
    DM-919
    Solid Tumor D2M Biotherapeutics Ltd
  • Preclinical
    DMR-001
    Essential Thrombocythemia$DMRA Damora Therapeutics, Inc.
  • Preclinical
    DPH-008
    Prostate Cancer Disruptive Pharma AB
  • Preclinical
    DPH-00X
    Unspecified Cancer Disruptive Pharma AB
  • Phase 2
    DPTX-3186
    Gastric Cancer Dewpoint Therapeutics Inc
  • Phase 1
    DS-1103
    Human Epidermal Growth Factor Receptor 2 Low Breast Cance… Integral Molecular Inc
  • Phase 1
    DS-2243
    Solid Tumor Daiichi Sankyo Co Ltd
  • Phase 2
    DS-3939
    Solid Tumor Daiichi Sankyo Co Ltd
  • Phase 1
    DS-5361
    Head And Neck Squamous Cell Carcinoma (HNSC) Daiichi Sankyo Co Ltd
  • Phase 1
    DS-9051
    Metastatic Castration-Resistant Prostate Cancer (mCRPC) Daiichi Sankyo Co Ltd
  • Phase 2
    DSP-107
    Colorectal Cancer KAHR medical Ltd
  • Preclinical
    DUET-101
    Bladder Cancer Duet Therapeutics Inc
  • Phase 1
    DVX-201
    Myelodysplastic Syndrome (Preleukemia)$COEP Coeptis Therapeutics Holdings, Inc.
  • Phase 2
    DX-126262
    Gastric Cancer Hangzhou DAC Biotech Co Ltd
  • Phase 2
    Decoy-20
    Adenoid Cystic Carcinoma (ACC)$INDP Indaptus Therapeutics, Inc.
  • Phase 1
    Deltacel
    Non-Small Cell Lung Cancer Immunocell Therapeutics Inc
  • Phase 1
    Diakine-DK210 (EGFR)
    Bladder Cancer Deka Biosciences Inc
  • Preclinical
    DisPATCH
    Solid Tumor RootPath Genomics Inc
  • Marketed
    Doxorubicin Teva
    Doxorubicin Hydrochloride (doxorubicin)
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk… Teva Pharmaceuticals USA Inc
  • Preclinical
    Drug to Inhibit MDM2 for Retinoblastoma
    Retinoblastoma Spectocular LLC
  • Preclinical
    Drugs for Oncology
    Pancreatic Ductal Adenocarcinoma SRI International
  • Phase 1
    E-7766
    Solid Tumor Eisai Co Ltd
  • Phase 2
    EB-103
    B-Cell Non-Hodgkin Lymphoma$ESLA Estrella Immunopharma, Inc.
  • Preclinical
    EB-104
    Acute Lymphocytic Leukemia (ALL, Acute Lymphoblastic Leuk…$ESLA Estrella Immunopharma, Inc.